Roche Holding AG (RHHVF)
241.36
-2.64
(-1.08%)
USD |
OTCM |
May 08, 13:27
Roche Market Cap: 192.43B for May 8, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 07, 2024 | 194.53B |
May 06, 2024 | 185.97B |
May 03, 2024 | 189.18B |
May 02, 2024 | 187.59B |
May 01, 2024 | 188.15B |
April 30, 2024 | 190.38B |
April 29, 2024 | 191.43B |
April 26, 2024 | 193.22B |
April 25, 2024 | 189.52B |
April 24, 2024 | 192.54B |
April 23, 2024 | 199.94B |
April 22, 2024 | 195.47B |
April 19, 2024 | 194.51B |
April 18, 2024 | 191.39B |
April 17, 2024 | 193.43B |
April 16, 2024 | 194.13B |
April 15, 2024 | 194.91B |
April 12, 2024 | 195.25B |
April 11, 2024 | 197.16B |
April 10, 2024 | 195.81B |
April 09, 2024 | 195.01B |
April 08, 2024 | 193.15B |
April 05, 2024 | 193.36B |
April 04, 2024 | 196.60B |
April 03, 2024 | 199.50B |
Date | Value |
---|---|
April 02, 2024 | 199.32B |
April 01, 2024 | 201.23B |
March 28, 2024 | 204.22B |
March 27, 2024 | 201.22B |
March 26, 2024 | 199.47B |
March 25, 2024 | 201.67B |
March 22, 2024 | 199.97B |
March 21, 2024 | 200.35B |
March 20, 2024 | 207.30B |
March 19, 2024 | 206.53B |
March 18, 2024 | 205.41B |
March 15, 2024 | 209.18B |
March 14, 2024 | 210.63B |
March 13, 2024 | 217.09B |
March 12, 2024 | 222.74B |
March 11, 2024 | 217.49B |
March 08, 2024 | 216.19B |
March 07, 2024 | 213.90B |
March 06, 2024 | 213.82B |
March 05, 2024 | 212.54B |
March 04, 2024 | 208.98B |
March 01, 2024 | 209.28B |
February 29, 2024 | 207.68B |
February 28, 2024 | 209.81B |
February 27, 2024 | 210.49B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
185.97B
Minimum
May 06 2024
356.53B
Maximum
Dec 29 2021
270.13B
Average
266.60B
Median
Market Cap Benchmarks
AC Immune SA | 232.41M |
CRISPR Therapeutics AG | 4.523B |
Addex Therapeutics Ltd | 9.769M |
NLS Pharmaceutics Ltd | 5.952M |
Molecular Partners AG | 119.92M |
Market Cap Related Metrics
PE Ratio | 15.08 |
PS Ratio | 2.866 |
Price to Book Value | 5.513 |
Price to Free Cash Flow | 15.14 |
Price | 241.36 |
Earnings Yield | 6.63% |
Operating PE Ratio | 11.27 |
Normalized PE Ratio | 14.90 |